Pages that link to "Q26823996"
The following pages link to Bcl-2 antagonists: a proof of concept for CLL therapy (Q26823996):
Displaying 19 items.
- Ultra-High-Throughput Screening of Natural Product Extracts to Identify Proapoptotic Inhibitors of Bcl-2 Family Proteins. (Q30397851) (← links)
- Richter's transformation to diffuse large B-cell lymphoma: a retrospective study reporting clinical data, outcome, and the benefit of adding rituximab to chemotherapy, from the Israeli CLL Study Group (Q30841807) (← links)
- Antagonism of Bcl-XL is necessary for synergy between carboplatin and BH3 mimetics in ovarian cancer cells (Q33431526) (← links)
- Gossypol increases expression of the pro-apoptotic BH3-only protein NOXA through a novel mechanism involving phospholipase A2, cytoplasmic calcium, and endoplasmic reticulum stress (Q33718487) (← links)
- The re-emergence of natural products for drug discovery in the genomics era. (Q34459318) (← links)
- Bilberry extract (Antho 50) selectively induces redox-sensitive caspase 3-related apoptosis in chronic lymphocytic leukemia cells by targeting the Bcl-2/Bad pathway. (Q35165791) (← links)
- Pharmacological and Protein Profiling Suggests Venetoclax (ABT-199) as Optimal Partner with Ibrutinib in Chronic Lymphocytic Leukemia (Q35958056) (← links)
- Cannabinoid Receptors Are Overexpressed in CLL but of Limited Potential for Therapeutic Exploitation (Q36036102) (← links)
- Idelalisib and bendamustine combination is synergistic and increases DNA damage response in chronic lymphocytic leukemia cells (Q37725415) (← links)
- Many players in BCL-2 family affairs (Q38185804) (← links)
- New dimension in therapeutic targeting of BCL-2 family proteins (Q38477617) (← links)
- CK2 and PI3K are direct molecular targets of quercetin in chronic lymphocytic leukaemia. (Q38704051) (← links)
- Current Treatment of Chronic Lymphocytic Leukemia. (Q39129372) (← links)
- Novel agents in mantle cell lymphoma (Q39290199) (← links)
- Norcantharidin combined with ABT-737 for hepatocellular carcinoma: Therapeutic effects and molecular mechanisms (Q39929571) (← links)
- Curcumin enhances the antitumor effect of ABT-737 via activation of the ROS-ASK1-JNK pathway in hepatocellular carcinoma cells (Q41853724) (← links)
- Getting the "Kill" into "Shock and Kill": Strategies to Eliminate Latent HIV. (Q47555333) (← links)
- BH3-only proteins: possible proapoptotic triggers for melanoma therapy. (Q52878050) (← links)
- NOTCH1 Represses MCL-1 Levels in GSI-resistant T-ALL, Making them Susceptible to ABT-263 (Q62644763) (← links)